Signant Health Introduces Agentic AI for Clinical Trial Supply
Philadelphia, Pennsylvania, August 3, 2026 Signant Health announced the launch of Forecasting & Planning Assistâ„¢, a purpose-built agentic AI...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Philadelphia, Pennsylvania, August 3, 2026 Signant Health announced the launch of Forecasting & Planning Assistâ„¢, a purpose-built agentic AI...
MONTPELLIER, France | January 28, 2026 — Sensorion, a clinical-stage biotechnology company focused on hearing loss disorders, announced a...
Milford, Massachusetts, January 20, 2026 — Waters Corporation, a global leader in analytical instruments, separations technologies, and laboratory software,...
SAN JOSE, Calif., January 20, 2026 — BrightInsight announced a $13 million strategic investment to accelerate development of its...
Cambridge, Massachusetts — January 8, 2026 — Nona Biosciences announced a strategic expansion of its integrated discovery and development...
Austin, Texas, and Minneapolis, Minnesota — January 8, 2026 — L7 Informatics and Turnberry Solutions announced a strategic teaming...
CAMBRIDGE, Mass. | January 8, 2026 — Diagonal Therapeutics, a biotechnology company developing disease-modifying clustering antibody therapies, announced the...
SAN DIEGO | January 8, 2026 — Just – Evotec Biologics, a collaboration between Evotec SE and Just –...
CALGARY, Alberta — December 4, 2025 — Hemostemix Inc., a leader in autologous stem-cell therapeutics, has appointed Shaune Harding,...
King of Prussia, Pennsylvania – October 31, 2025 — Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing...
